Sage Journals: Discover world-class research

Abstract

The mammalian circadian timing system consists of a master pacemaker in the suprachiasmatic nucleus (SCN) and subordinate clocks that disseminate time information to various central and peripheral tissues. While the function of the SCN in circadian rhythm regulation has been extensively studied, we still have limited understanding of how peripheral tissue clock function contributes to the regulation of physiological processes. The adrenal gland plays a special role in this context as adrenal hormones show strong circadian secretion rhythms affecting downstream physiological processes. At the same time, they have been shown to affect clock gene expression in various other tissues, thus mediating systemic entrainment to external zeitgebers and promoting internal circadian alignment. In this review, we discuss the function of circadian clocks in the adrenal gland, how they are reset by the SCN and may further relay time-of-day information to other tissues. Focusing on glucocorticoids, we conclude by outlining the impact of adrenal rhythm disruption on neuropsychiatric, metabolic, immune, and malignant disorders.

Keywords

adrenal clock circadian rhythms clock genes glucocorticoids aldosterone

The environmental changes associated with the rhythmic succession of night and day have led to the development of endogenous biological timekeepers in most organisms that allow for intrinsic timing of biological processes and behaviors at the appropriate time of day. Circadian clocks (from the Latin circa diem—about a day) allow for reliable timekeeping with a period of close to 24 h without external stimuli but are synchronized to geophysical time by signals such as light and food (so-called zeitgebers, German for “time givers”). Circadian rhythms of behavior and physiology, such as hormone secretion, in mammals are coordinated by the hypothalamic suprachiasmatic nucleus (SCN). The SCN receives light input from the retinohypothalamic tract and relays this information to downstream cellular clocks in various tissues of the body. Our current understanding of the molecular circadian clock is that it is built from interlocked transcriptional-translational feedback loops formed by components of positive (BMAL1, CLOCK, NPAS2) and negative (PER1 and PER2, CRY1 and CRY2) limbs (Brown et al., 2012). In mammals, most if not all tissues and cells contain their own molecular oscillators (Dibner et al., 2010) built from the same components as that of the SCN pacemaker.

From a chronobiological perspective, the adrenal gland is of particular interest. Adrenal endocrine functions show circadian regulation, and glucocorticoid (GC) rhythms appear to have a key role in synchronizing peripheral clocks downstream of the SCN. Apart from direct effects of rhythmic GC secretion on physiology, which include mediation of stress responses as well as immune and cognitive modulation, GC rhythms may therefore be involved in the adaptation of the circadian system under environmental pressures such as jetlag or shiftwork. Other adrenal hormones such as aldosterone and catecholamines also show time-of-day dependent modulation. The circadian effects of these hormones, however, are less well studied, although they might serve as important regulators of physiological rhythms.

Control of Adrenal Hormone Rhythms

The adrenal cortex produces 3 classes of hormones: mineralocorticoids (MCs) in the outer zona glomerulosa, GCs (primarily cortisol in humans and corticosterone in rodents) in the intermediate zona fasciculata, and, in some mammals, sex steroids in the inner zona reticularis (Figure 1A). GCs are released in a rhythmic fashion under nonstressed conditions with circadian, ultradian, and seasonal patterns (Dickmeis et al., 2013). The robust circadian rhythm of GC secretion and its reliance on the SCN as the master pacemaker has been established for several decades, persisting despite constant environmental conditions and abolished when the SCN is surgically removed (Moore and Eichler, 1972; Stephan and Zucker, 1972). In contrast, the ultradian or pulsatile rhythm, which overlays the circadian pattern with a period of 80 to 110 min in humans (Figure 1B), occurs independent of SCN input (Waite et al., 2012) and persists even when the hypothalamus and pituitary are surgically disconnected (Engler et al., 1990). GCs are also rapidly secreted in response to acute stress, along with epinephrine from the adrenal medulla. GC targets include glucose homeostasis and immune and cognitive functions. Acute GC effects are primarily exerted by the glucocorticoid receptor (GR, also known as NR3C1), which is widely expressed throughout the body and within the brain, with the notable exception of the SCN (Balsalobre et al., 2000). GCs also bind to and activate the mineralocorticoid receptor (MR), which is expressed in a more select distribution of tissues (Reul and de Kloet, 1985). GCs bind to MR with high affinity, while they rapidly dissociate from GR, allowing for more tonic MR-mediated GC signaling. GRs, on the other hand, are activated only during peaks of ultradian GC pulses or during the stress response (de Kloet et al., 2005).

Figure 1.

(A) Anatomy of adrenal gland. M = medulla; Cx = cortex; F = zona fasciculata; G = zona glomerulosa. (B) A schematic view of 24-h secretion of plasma corticosterone in the rat (redrawn from Sarabdjitsingh et al., 2010). Circadian variation is represented by a smoothing line. (C) A representative 1-day bioluminescence imaging of a murine PER2::LUC adrenal slice. Note that a peak of the luminescence signal in the adrenal medulla is delayed compared with the cortex.

While pulsatile GC release is controlled by a negative feedback loop involving GR signaling and adrenocorticotropic hormone (ACTH) suppression in the pituitary (Walker et al., 2012), circadian GC rhythms are regulated by 3 main factors: (1) the endocrine hypothalamic-pituitary-adrenal (HPA) axis, (2) SCN-controlled autonomic innervation, and (3) local adrenocortical circadian clocks (Figure 2A). In the HPA axis, circadian information from the SCN (Buijs et al., 1993) and stress-driven signals from the brainstem and the limbic structures of the forebrain (Ulrich-Lai and Herman, 2009) stimulate production of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) at the paraventricular nucleus of the hypothalamus (PVN). These signals reach the corticotropes of the anterior pituitary via the blood portal system and stimulate secretion of corticotropin ACTH into circulation. ACTH then activates adrenocortical steroidogenesis via the melanocortin 2 receptor (MC2R) and subsequent cAMP-PKA pathways, which stimulate the transcription of steroidogenic genes such as cholesterol side chain cleavage enzyme (CYP11A1) and steriodogenic acute regulatory protein (StAR). Cholesterol is transported into the adrenal cortex via SR-BI and LDL receptors and then into the mitochondria by StAR, which is the rate-limiting step of GC biosynthesis.

Figure 2.

(A) Circadian regulation of GC rhythms. ACTH = adrenocorticotropic hormone; ANS = autonomic nervous system; CA = catecholamines; GC = glucocorticoids; HC = hippocampus; MC = mineralocorticoids; PVN = paraventricular nucleus; RHT = retinohypothalamic tract; SCN = suprachiasmatic nucleus; StAR = steroidogenic acute regulatory protein. See the text for explanations. (B) Circadian regulation of GC action. Prior to binding to glucocorticoid receptor (GR), bioavailability of GCs is regulated by blood levels of corticosteroid-binding globulin (CBG), local activity of GC-converting 11β-hydroxysteroid dehydrogenase (HSD) enzymes in target cells, and transport through the blood-brain barrier by P-glycoprotein (Pgp) (Quax et al., 2013). Notably, circadian variation has been reported in the expression of all these components and of GR, at least in some tissues (Hsu and Kuhn, 1988; Ando et al., 2005; Yang et al., 2006; Buren et al., 2007). Activated GRs modulate gene transcription through binding to glucocorticoid response elements (GRE) in regulatory regions of many genes, including clock genes Per1, Per2, Npas2, and others (So et al., 2009). In turn, circadian clock components can interact with GR and inhibit its activity, as has been reported for CRY and CLOCK proteins (Nader et al., 2009; Lamia et al., 2011).

The circadian GC peak occurs a few hours before the onset of the active phase. Thus, the timing of GC peaks differs between diurnally and nocturnally active species (Lightman and Conway-Campbell, 2010). Upstream of GC secretion, circulating ACTH shows a similar circadian profile (Henley et al., 2009). CRH expression in the PVN is also rhythmic (Watts et al., 2004), but CRH phasing is not well synchronized with the expression of pro-opiomelanocortin (POMC, the precursor of ACTH) in the pituitary and circulating levels of GCs (Watts et al., 2004; Girotti et al., 2009), and in CRH knockout mice, a constant infusion of CRH is sufficient to rescue diurnal GC rhythms (Muglia et al., 1997). In a similar manner, the rhythmic release of ACTH is not essential for rhythmic GC secretion (Lilley et al., 2012), arguing against a primary regulation of circadian GC rhythms via the HPA axis. In contrast, recent in vitro findings suggest that ACTH is capable of resetting the adrenal clock rhythms (Yoder et al., 2014). Hence, HPA axis activity, although not critical for generation of daily GC rhythms, may contribute to adjustment of circadian phase of hormonal production.

A second communication pathway from the SCN to the adrenal gland runs via the autonomic nervous system (ANS). Since hypophysectomy only ablates GC rhythms in combination with adrenal denervation (Meier, 1976; Ottenweller and Meier, 1982), this may explain the above-mentioned dissociation between GC rhythms and upstream components of the HPA axis. SCN-derived ANS signals travel via preautonomic PVN neurons and sympathetic preganglionic intermediolateral neurons of the spinal cord, and they finally reach the adrenal gland, which is innervated by the splanchnic nerve (Buijs et al., 1999). Splanchnic nerve transsection in rats reduces the peak of plasma GC rhythms compared to sham-operated animals (Ulrich-Lai et al., 2006; Wotus et al., 2013). This autonomic innervation of the adrenal gland also provides a rapid photic input to the adrenal, with a 30-min light pulse being able to stimulate adrenal Per1 expression and secretion of GC independent of ACTH (Ishida et al., 2005). It remains unclear how sympathetic nerves regulate adrenal GC production (reviewed in Engeland, 2013). Medullary-cortical signaling via catecholamines and neuropeptides as well as sympathetic regulation of intra-adrenal blood flow has been proposed as potential pathways (Engeland, 2013). For instance, adrenal demedullation experiments suggest that an intact adrenal medulla, a primary target of preganglionic sympathetic fibers, is required for both proper circadian peak of plasma GCs and acute GC responses to light (Ishida et al., 2005; Ulrich-Lai et al., 2006).

Although the SCN is clearly essential for the rhythmic secretion of adrenal hormones in vivo, already in the 1960s, isolated and cultured Syrian hamster adrenal glands were demonstrated to have robust circadian rhythms of respiration and steroid secretion (Andrews and Folk, 1964). More recently, this property was also shown in adrenocortical Y-1 cells (Son et al., 2008). This initial observation occurred before the discovery of the molecular adrenal clockwork, but it is now well understood that clock gene expression in the rodent and primate adrenal gland, particularly in the adrenal cortex, is highly rhythmic (Bittman et al., 2003; Lemos et al., 2006; Oster et al., 2006a, 2006b; Fahrenkrug et al., 2008; Valenzuela et al., 2008) (Figure 1C), and a circadian pattern of expression applies to approximately 10% of the adrenal transcriptome, including genes involved in cholesterol uptake, regulators of steroidogenesis, and ACTH signaling (Oster et al., 2006a). In particular, the key steroidogenesis rate-limiting cholesterol transporter StAR is rhythmically expressed under the direct regulation of adrenal clock proteins (Ulrich-Lai et al., 2006; Son et al., 2008). Furthermore, sensitivity to ACTH appears to be regulated by a circadian gating mechanism in the adrenal clock (Oster et al., 2006b). In line with this, hypocortisolism and diminished expression of transcripts important for steroidogenesis and cholesterol transport were observed in Bmal1 knockout mice, as well as impaired behavioral responsiveness to stress and a blunted GC response to ACTH stimulation in cultured adrenal tissue (Leliavski et al., 2014).

The molecular clock also controls the sympathoadrenal function and the release of catecholamines—norepinephrine and epinephrine—from the adrenal medulla (Curtis et al., 2007). Plasma and urinary catecholamine levels follow moderate diurnal oscillations, with elevated levels during the active phase, and their production is severely reduced in the Bmal1-deficient mice (Curtis et al., 2007). Furthermore, we and others have reported rhythmic expression of adrenal transcripts critical for catecholamine metabolism, such as Maoa, Nr4a2, and Pnmt (Oster et al., 2006a, 2006b; Curtis et al., 2007). Circadian rhythms in the adrenal medulla are preserved ex vivo (e.g., in PC12 chromaffin cells) (Lemos et al., 2007) and in PER2::LUC adrenal slices (Figure 1C). It has not been tested to what extent a compromised SCN clock would affect diurnal rhythms of catecholamine secretion by adrenal medulla and how important local oscillators are in this context. In the liver, however, it has been shown that daily rhythms of norepinephrine content are flattened in SCN-lesioned animals compared to controls (Terazono et al., 2003). Considering that the adrenal medulla is necessary for the autonomic regulation of GC release (Ishida et al., 2005), it is tempting to speculate that communication between adrenocortical and medullary circadian clocks may be involved in the coordination of adrenal endocrine rhythms (see also Ehrhart-Bornstein et al., 1998).

Rhythmic release has also been reported for the mineralocorticoid aldosterone (Wolfe et al., 1966; Doi et al., 2010). A critical role of the adrenocortical clock in regulation of blood pressure has been demonstrated in Cry1/2-deficient mice that show constantly high plasma aldosterone levels and develop hypertension when challenged with a high-salt diet (Doi et al., 2010). In contrast, Bmal1 knockout mice are hypotensive (Curtis et al., 2007). Cry1/2^−/− mice show elevated transcription and enhanced enzymatic activity of type VI 3β-hydroxyl-steroid dehydrogenase (Hsd3b6), which is expressed exclusively in aldosterone-producing cells under transcriptional control of the circadian clock. Importantly, this enzyme is functionally conserved in humans, and the pathophysiology of human idiopathic hyperaldosteronism resembles that of Cry1/2-deficient mice (reviewed in Doi, 2012; Ota et al., 2012). Moreover, single-nucleotide polymorphisms in the HSD3B1 gene, the human ortholog of Hsd3b6, are associated with elevated systolic and diastolic blood pressure and plasma aldosterone activity (Rosmond et al., 2002; Shimodaira et al., 2010). Further studies are needed to clarify to which extent the circadian clock function in adrenal zona glomerulosa cells confers a risk of developing hypertension in humans and to what extent rhythmic autonomic innervation may impinge on aldosterone release.

Clinical Implications of Adrenal GC Rhythms

Rapid changes in the light-dark cycle or sleep rhythm disruption as occur during jetlag or shift work lead to a misalignment of internal circadian clocks and external time. In addition, conflicting zeitgeber information (e.g., by mistimed food intake) may further disrupt internal circadian synchrony. Such external and internal misalignment is associated with several health disorders, and GC rhythms play an important role in this context due to their capacity to reset tissue clocks via GR signaling (Balsalobre et al., 2000; So et al., 2009; Lamia et al., 2011) (Figure 2B). While the SCN pacemaker is insulated from direct GC feedback due to a lack of GR expression, GCs exert a stabilizing effect on peripheral tissue rhythms against external zeitgeber influence (Le Minh et al., 2001; Oishi et al., 2005; Kiessling et al., 2010; Pezuk et al., 2012).

Importantly, rhythmic GC secretion contributes to the homeostatic regulation of various biological processes, including long-term memory formation in mice and humans (Wagner and Born, 2008; Liston et al., 2013), hippocampal neurogenesis (Dickmeis and Foulkes, 2011), T-cell levels in human blood (Dimitrov et al., 2009), proliferation of murine hematopoietic progenitor cells (Kollet et al., 2013), and cell cycle activity in zebrafish (Dickmeis et al., 2007). Hence, the disruption of daily GC oscillations might be deeply linked with pathology. In the following sections, we will consider potential connections between circadian rhythms of GC production or GC sensitivity and a number of diseases (summarized in Table 1) and suggest therapeutic approaches to incorporate GC rhythm manipulation in the clinic.

Table 1.

GC Production and Signaling in Disease.

Type of Alterations	Disease/Disease Model	References
Flattened/dampened amplitude of GC rhythms	Major depression	(Krieger, 1975; Alesci et al., 2005; Heaney et al., 2010; Jarcho et al., 2013; Li et al., 2013b)
	Posttraumatic stress disorder	(Yehuda et al., 2005)
	Obesity	(Ljung et al., 1996; Rosmond et al., 1998; Ljung et al., 2000; Walker et al., 2000; Kohsaka et al., 2007)
	Obese Zucker rats	(Martin et al., 1978; Walker et al., 1992)
	Obese db/db mice	(Ahima et al., 1998)
	Type 2 diabetes	(Lederbogen et al., 2011)
	EAE (multiple sclerosis)	(Buenafe, 2012)
	MRL/MP-fas^lpr mice (lupus)	(Lechner et al., 2000)
	Adjuvant-induced arthritis in rats (rheumatoid arthritis)	(Sarlis et al., 1992)
	Active rheumatoid arthritis	(Dekkers et al., 2001)
	Some cancers (breast, lung, ovary, kidney)	(Sephton et al., 2000; Weinrib et al., 2010; Cohen et al., 2012; Kim et al., 2012; Sephton et al., 2013)
Phase delay of GC rhythm	Seasonal affective disorder	(Avery et al., 1997)
Phase advance of GC rhythm	Brd mice (schizophrenia)	(Oliver et al., 2012)
Reduced GC bioavailability (arrhythmic 11β-HSD1 expression)	Obese Zucker rats	(Buren et al., 2007)
Reduced GC bioavailability (elevated plasma CBG)	OS chickens (spontaneous autoimmune thyroiditis)	(Fassler et al., 1986; Schauenstein et al., 1987; Fassler et al., 1988)
Adrenal hyporesponsiveness to ACTH	Rheumatoid arthritis	(Cutolo et al., 2006)
Adrenal hyporesponsiveness to ACTH	UCD 200 chickens (scleroderma)	(Brezinschek et al., 1993)
Adrenal hyperresponsiveness to ACTH	MRL/MP-fas^lpr mice (lupus)	(Lechner et al., 2000)
Adrenal hyperresponsiveness to ACTH	NZB mice (hemolytic anemia)	(Lechner et al., 2000)
Reduced GR expression in target tissues	Nocturnal asthma (in peripheral blood mononuclear cells)	(Kraft et al., 1999)
	Bipolar disorder, major depression, schizophrenia (in hippocampus)	(Webster et al., 2002)

CBG = corticosteroid-binding globulin; EAE = experimental autoimmune encephalomyelitis; GC = glucocorticoid; OS = obese strain.

GC Rhythms and Mood Disorders

Several lines of evidence suggest a bidirectional link between the circadian clock, mood regulation, and mood disorders (reviewed in Wulff et al., 2010; Albrecht, 2013; McClung, 2013; Karatsoreos, 2014; LeGates et al., 2014). Disrupted circadian rhythms (e.g., as a result of shift work) facilitate the development of mood disorders and are associated with the disease severity in some susceptible individuals (Albrecht, 2013). Similarly, mice exposed to aberrant light conditions (an extremely short 7-h light-dark cycle) develop a depressive phenotype and suffer from hypercortisolism (LeGates et al., 2012). On the other hand, patients with mood disorders benefit from daily routines that include adherence to a strict bedtime (Frank et al., 2000). Polymorphisms in human clock genes and several clock gene deficiencies in mice are associated with sleep abnormalities and depressive or manic behavior (Kennaway, 2010; Albrecht, 2013). For instance, circadian clock-deficient mice, such as Per2 and Clock mutants, reveal behavioral signs of mania (Roybal et al., 2007; Hampp et al., 2008).

HPA axis hyperactivity due to impaired negative feedback is one of the best documented clinical findings in patients with major depressive disorder (MDD) (Holsboer, 2000). Studies of circadian rhythms of GC hormones in depressive patients yielded somewhat mixed results (see Jarcho et al., 2013, for discussion). However, a general agreement is that MDD is associated with a flattening of diurnal GC rhythms (Krieger, 1975; Alesci et al., 2005; Heaney et al., 2010; Jarcho et al., 2013; Li et al., 2013b), which is explained by reduced brain sensitivity to negative GC feedback (de Kloet et al., 1998; Holsboer, 2000). Depressive patients show disruptions of daily rhythms of clock gene expression in blood cells (Li et al., 2013b) and various brain areas (Li et al., 2013a), which could to some extent be explained by altered GC rhythms (Segall et al., 2009). The phenomenon of the switch from depression to the opposite states of mania or hypomania and vice versa distinguishes bipolar disorder (BD) from all other psychiatric disorders (Salvadore et al., 2010). Disruptions of sleep (insomnia or hypersomnia) and circadian rhythms, including abnormal function of HPA axis, are core features of BD (Milhiet et al., 2011). In patients with seasonal affective disorder (SAD; also known as winter depression), early reports suggest that there are no significant changes of circadian GC production and GC-mediated negative feedback (James et al., 1986; Skwerer et al., 1988; Joseph-Vanderpool et al., 1991; Oren et al., 1996). However, using a constant routine protocol, phase-delayed cortisol and body temperature rhythms in SAD patients have been demonstrated (Avery et al., 1997). The normal inhibition of cortisol secretion during early sleep was absent in patients with schizophrenia, although the phasing and amplitude of the morning cortisol peak were not affected (Van Cauter et al., 1991). Additionally, in Brd mice, a murine model of schizophrenia, the 24-h rhythms of plasma corticosterone are advanced (Oliver et al., 2012).

In light of the association between altered GC rhythms and mood disorders, the following question arises: how may disturbed circadian rhythms of GCs contribute to the pathogenesis of these conditions? Several pathways might be involved (for a review, see McClung, 2013). (1) GC rhythms regulate circadian gene expression in the dentate gyrus and are necessary for the proliferation of neural progenitor cells in response to antidepressant treatment (Huang and Herbert, 2006; Gilhooley et al., 2011). Moreover, brain-derived neurotrophic factor (BDNF) and its receptor, TrkB, are rhythmically expressed in the hippocampus and are important for the action of antidepressant medications (Schaaf et al., 2000; Dolci et al., 2003). Importantly, BDNF loses its proliferative effects in the absence of daily rhythms in corticosterone (Pinnock and Herbert, 2008). (2) Disrupted GC rhythms may affect monoamine signaling in the brain. GCs modulate extracellular levels of monoamine neurotransmitters, including serotonin, noradrenaline, and dopamine, major targets of current antidepressant therapy (Mora et al., 2012). (3) Altered GC rhythms may affect mood via deregulation of metabolism. Indeed, epidemiological studies report that MDD often correlates with obesity, insulin resistance, and diabetes (Onyike et al., 2003; Pearson et al., 2010). Similarly, hypercortisolic Cushing’s patients with central obesity also have an increased risk of developing MDD (Pereira et al., 2010). (4) Further GC effects may be mediated via their suppressive effect on the immune system. Reduced sensitivity to inhibitory GC action, as seen in depressive patients, promotes secretion of proinflammatory cytokines (Alesci et al., 2005), which may in turn exacerbate depressive symptoms. In conclusion, although clinical data extensively document altered GC rhythms in psychiatric patients, we ought to note that the molecular pathways and causative links underlying the hormonal disruption are rather speculative and should be hence scrutinized in further studies using animal models.

GC Rhythms and Metabolic Disorders

Complex interactions are found between the circadian clock and metabolic pathways, and GC rhythms play an important role in this context (reviewed in Kovac et al., 2009; Nader et al., 2010; Bass, 2012). Human obesity is associated with a flattening of diurnal cortisol rhythms, although changes in overall GC levels are less consistent between studies. Elevated trough corticosteroid levels and dampened or disrupted GC rhythmicity have been reported in obese adults (Ljung et al., 1996; Rosmond et al., 1998; Ljung et al., 2000; Walker et al., 2000), genetically obese Zucker rats (Martin et al., 1978; Walker et al., 1992), and db/db mice (Ahima et al., 1998), as well as in mice with gold-thioglucose-induced obesity (Saito and Bray, 1983). Leptin-deficient ob/ob mice exhibit overall increased GC production with preserved circadian rhythmicity (Saito and Bray, 1983). Of note, overweight and obese children also show a reduced amplitude of GC rhythms and overall reduced GC secretion (Kjolhede et al., 2014), resembling the findings from diet-induced obese mice (Kohsaka et al., 2007). Finally, a flattened 24-h profile of salivary cortisol, with lower cortisol concentrations in the morning and higher in the afternoon and evening, is reported in diabetic subjects (Lederbogen et al., 2011). The circadian clock may affect rhythms of GC sensitivity in tissues, leading to metabolic abnormalities. For instance, Cry-deficient mice that show reduced suppression of HPA axis and thus constitutively high GC levels develop glucose intolerance and signs of metabolic syndrome (Lamia et al., 2011; Barclay et al., 2013).

GC Rhythms and Inflammatory Disorders

GCs play an essential role in the regulation of inflammation and are widely used as immunosuppressive agents for treating chronic inflammatory disorders, including autoimmune pathology (Busillo and Cidlowski, 2013). Proinflammatory cytokines, such as interleukin (IL)-6, tumor necrosis factor (TNF)-α, and IL-1β, potentiate the activity of HPA axis, exerting a feedback inhibition of immune responses and therefore minimizing excessive damage of host tissues (Wick et al., 1993). Daily rhythmic changes occur in basal activity of the immune system and are, at least partially, controlled by GC rhythms (reviewed in Lange et al., 2010; Cermakian et al., 2013). Corticosterone responses to an acute inflammatory stimulus (lipopolysaccharide injection) in rodents follow diurnal variations with a peak of sensitivity in the morning (Guo et al., 1996; Kalsbeek et al., 2012). Diurnal variation in immune reactivity is often preserved in autoimmune diseases; however, deregulated interactions along the immune-HPA axis lead to compromised ability of GCs to suppress pathological inflammation (Wick et al., 1993). Indeed, many patients with asthma and rheumatoid arthritis (RA) have worsening of symptoms in early morning (i.e., close to the peak of cortisol secretion) (reviewed in Cutolo et al., 2006; Burioka et al., 2010; Haus et al., 2012). For instance, it has been demonstrated that a peak of IL-6 secretion in arthritic parents precedes that of cortisol by less than 1 h (Perry et al., 2009). This paradoxical failure of GCs to suppress exacerbated inflammatory activity in the morning, at the peak of GC production, can be explained by impaired GC sensitivity of immune cells. Indeed, nocturnal asthma is associated with reduced GR binding activity and decreased responsiveness of blood leukocytes to GCs at early morning (Kraft et al., 1999). RA patients left untreated with GCs show impaired cortisol responses despite preserved ACTH secretion. This is consistent with a “relative adrenal insufficiency” in the presence of sustained inflammatory processes, allowing for excessive cytokine production in the late night (Cutolo et al., 2006). On the other hand, Lechner et al. (2000) found that increased GC production during the light phase in MRL/MP-fas^lpr mice was not associated with a corresponding surge of plasma ACTH levels, which may point to an adrenal hypersensitivity to ACTH. Similar abnormalities in adrenal responsiveness were reported in other mouse strains that develop spontaneous autoimmune pathology, such as hemolytic anemia (NZB) and lupus ([NZB/W]-F1; summarized in Lechner et al., 2000). Interestingly, impaired HPA axis activity in lupus-prone mice is observed well before the onset of clinical symptoms, suggesting a potential prognostic value of deregulated GC rhythms in lupus (Wick et al., 1993). Considering that the adrenal clock is involved in the regulation of ACTH sensitivity, further studies may elucidate a role for this molecular clockwork in the deregulated adrenal responsiveness to ACTH in immune disorders. In this context, it is particularly interesting to note that inflammatory mediators such as IL-6 can directly act on adrenocortical cells and stimulate corticosterone release synergistically with ACTH (Ehrhart-Bornstein et al., 1998).

GC Rhythms and Cancer

Altered circadian rhythms, including deregulated GC rhythmicity, may promote cancer development (Mormont and Levi, 1997; Levi et al., 2010). Epidemiological studies have shown the increased cancer risk in shift workers with prolonged exposure to night-shift work (Schernhammer et al., 2001; Megdal et al., 2005; Stevens, 2009; Stevens et al., 2011). Similarly, experimental circadian disruption resulting from chronic jet lag, SCN lesion, or Per2 deficiency significantly facilitates formation and progression of tumors, whether implanted or induced by carcinogenic treatment (van den Heiligenberg et al., 1999; Fu et al., 2002; Filipski et al., 2006; Filipski et al., 2009; but also compare: Gauger and Sancar, 2005; Antoch et al., 2008). Flattened or even reversed diurnal rhythms of cortisol secretion are associated with reduced survival in patients with metastatic or advanced breast, lung, ovarian, and kidney cancers, compared to patients with robust circadian rhythms (Sephton et al., 2000; Weinrib et al., 2010; Cohen et al., 2012; Kim et al., 2012; Sephton et al., 2013). This phenomenon is independent of other known prognostic factors and persists many years after testing (Innominato et al., 2014). Whether disrupted GC rhythms may actually influence malignant growth is less clear. Timed daily administration of corticosterone in combination with prolactin, but neither hormone alone, for 10 days after inoculation of fibrosarcoma has been shown to have a significant inhibitory effect on the tumor growth in mice (Keisari et al., 1999). Nevertheless, other scenarios should be considered in further preclinical studies to scrutinize a potential role of impaired GC rhythms in malignancy. For instance, GCs can modulate immune responses to cancer cells, promote accumulation of fatty acids and glucose in metabolic depots, and act directly on tumor cells affecting cell cycle progression, cellular metabolism, and the circadian clock (reviewed in Dickmeis and Foulkes, 2011; Volden and Conzen, 2013).

In summary, disruption of daily GC rhythms, especially due to elevated trough levels, is commonly observed in various pathological conditions (Table 1). Further studies are necessary to dissect the contribution of central and peripheral (adrenocortical) clocks in this context.

GC Chronotherapy

Pharmacological correction of diurnal GC rhythmicity can be achieved by timed administration of exogenous GCs or by time-of-day-dependent suppression of abnormal overproduction of adrenal hormones. GC substitution is the mainstay of treatment in most hypocortisolemic disorders, regardless of their etiology (i.e., primary adrenal failure vs. secondary pituitary corticotrope or hypothalamic anatomical damage or functional impairment) (Coursin and Wood, 2002; Husebye et al., 2014). Major goals of chronic GC replacement are to substitute as much hydrocortisone (HC) as necessary to guarantee adequate stress reactivity and to avoid symptoms of chronic adrenal insufficiency (e.g., fatigue, nausea, or weight loss) (Husebye et al., 2014). Simultaneously, care must be taken to administer as little HC as possible to avert detrimental side effects of GC excess, such as weight gain (Huscher et al., 2009), neuropsychiatric symptoms (Dubovsky et al., 2012), osteoporosis (Lovas et al., 2009), and impaired glucose tolerance (Kwon and Hermayer, 2013). With respect to cumulative physiological cortisol secretion of approximately 3 to 12 mg/m² per 24 h (Kraan et al., 1998; Purnell et al., 2004) and to the endogenous circadian rhythm of adrenal cortisol secretion, typical current clinical dosing regimens aim to substitute between 15 and 25 mg of HC per day in 3 divided doses. Roughly two-thirds of the cumulative HC dose is administered in the morning (e.g., 15 mg at 0700 h), while the remainder is split between 2 doses (e.g., 5 mg at 1200 h and 1700 h, respectively) (Husebye et al., 2014). Timing the last HC dose of the day sufficiently early (i.e., at least 5-6 h before bedtime) effectively prevents sleep disruption as a consequence of supra-physiological bedtime cortisol concentrations. The need for thrice-daily HC administration represents a significant challenge to therapy adherence. Furthermore, cortisol spikes after the midday and afternoon doses in addition to subphysiological cortisol concentrations preceding the administration of the next dose likely contribute to the excess mortality in patients with adrenal insufficiency on GC replacement therapy (Lovas et al., 2003; Debono et al., 2009). An oral dual-release HC preparation is being tested in the treatment of adrenal insufficiency (Lovas and Husebye, 2007; Johannsson et al., 2009; Johannsson et al., 2012). This preparation combines an outer coating layer that provides an immediate release of the drug and an extended-release HC core (Nilsson et al., 2014). This formulation has been shown to be safe and effective in more efficiently mimicking the natural circadian cortisol rhythm in patients with adrenal insufficiency (Johannsson et al., 2009; Johannsson et al., 2012). This improved approximation of the physiological circadian cortisol rhythm translated into improved quality of life, reduced body weight, decreased blood pressure, and improved glucose metabolism in a study involving 64 patients with primary adrenal insufficiency (Johannsson et al., 2012). A small study involving 7 patients with primary adrenal insufficiency moreover demonstrated that continuous subcutaneous HC infusion by programmable infusion pumps was sufficient to imitate the physiological circadian cortisol secretory rhythm, thus allowing for a substantial reduction in HC substitution requirements without adverse effects (Lovas and Husebye, 2007). Refining this paradigm, a pulsatile subcutaneous HC infusion pump has been validated to more closely mimic ultradian and circadian cortisol secretory pulsatility and showed that at comparable overall GC exposure, the pulsatile versus smooth pattern of cortisol secretion shapes a particular gene transcription pattern and subsequently specific neuroendocrine responses (Russell et al., 2014). This approach, although still experimental, may be especially beneficial in patients with pronounced morning fatigue, who are speculated to be more sensitive to the absence of the physiological cortisol peak shortly before awakening, and inherently cannot be addressed by oral HC substitution.

Desynchrony between external time and endogenous circadian clocks, as observed during jetlag or shiftwork, has been associated with fatigue and sleep disorders (Weingarten and Collop, 2013), an increased incidence of malignancy (Haus and Smolensky, 2013), and psychiatric disturbances (Katz, 2011). As mentioned above, numerous cell and animal studies suggest a pivotal role of adrenal GCs in the entrainment of central and peripheral rhythms and clocks (Balsalobre et al., 1998; Balsalobre et al., 2000; Sage et al., 2004; Kiessling et al., 2010). Investigating the impact of desynchronized secretory GC rhythms on human glucose metabolism, Plat et al. (1999) found a significant increase in glucose and insulin levels when HC levels were artificially elevated at night. To examine the impact of modulating the adrenal glucocorticoid secretory rhythm on recovery from jetlag, Kiessling et al. (2010) induced a phase shift in GC secretion by timed administration of the steroidogenesis inhibitor metyrapone in mice. Depending on the direction of the induced shift relative to the external time shift, metyrapone treatment either accelerated or decelerated the duration of jet lag, as manifested by the speed of reentrainment of behavioral and clock gene transcriptional rhythms (Kiessling et al., 2010). This evidence complements the Plat et al. (1999) study, which demonstrated such GC shifting to be feasible in humans. Thus, the capacity of adrenal glucocorticoids to stabilize or reentrain circadian rhythms represents an exciting therapeutic approach to develop treatment strategies for human jetlag and circadian disruption-associated morbidity.

Conclusion

Adrenal clocks and adrenal-derived endocrine rhythms have important functions in the regulation of physiological processes, and adrenal circadian disruption may be an important step in the development of a number of heterogeneous diseases. While we have gained some insight into the regulation of adrenal rhythms by the SCN, it will be important to better describe the interaction of circadian and noncircadian factors in the control of adrenal activity. On the other hand, the role of the adrenal hormones as resetting signals for other tissues deserves further attention, particularly with regard to the development of complex pathologies such as major depression or various immune disorders. Furthermore, the better accessibility of peripheral clocks may actually make them more attractive targets for chronotherapeutic approaches than the SCN pacemaker itself.

Footnotes

Acknowledgements

HO is a Lichtenberg fellow of the Volkswagen Foundation. This work was supported by a project grant of the German Research Foundation (DFG). VO is supported by a grant from the German Ministry of Education and Science (BMBF).

Author Contributions

AL performed experiments. AL & HO analysed the data. AL, RD, VO and HO wrote the manuscript.

Conflict of Interest Statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

Ahima

Prabakaran

Flier

(1998) Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding: Implications for energy homeostasis and neuroendocrine function. J Clin Invest 101:1020-1027.

Albrecht

(2013) Circadian clocks and mood-related behaviors. Handb Exp Pharmacol 217:227-239.

Alesci

Martinez

Kelkar

Ilias

Ronsaville

Listwak

Ayala

Licinio

Gold

Kling

. (2005) Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90:2522-2530.

Ando

Yanagihara

Sugimoto

Hayashi

Tsuruoka

Takamura

Kaneko

Fujimura

(2005) Daily rhythms of P-glycoprotein expression in mice. Chronobiol Int 22:655-665.

Andrews

Folk

Jr. (1964) Circadian metabolic patterns in cultured hamster adrenal glands. Comp Biochem Physiol 11:393-409.

Antoch

Gorbacheva

Vykhovanets

Toshkov

Kondratov

Kondratova

Lee

Nikitin

(2008) Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle 7:1197-1204.

Avery

Dahl

Savage

Brengelmann

Larsen

Kenny

Eder

Vitiello

Prinz

(1997) Circadian temperature and cortisol rhythms during a constant routine are phase-delayed in hypersomnic winter depression. Biol Psychiatry 41:1109-1123.

Balsalobre

Brown

Marcacci

Tronche

Kellendonk

Reichardt

Schutz

Schibler

(2000) Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289:2344-2347.

Balsalobre

Damiola

Schibler

(1998) A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93:929-937.

10.

Barclay

Shostak

Leliavski

Tsang

Johren

Muller-Fielitz

Landgraf

Naujokat

van der Horst

Oster

(2013) High fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry deficient mice. Am J Physiol Endocrinol Metab 304:E1053-E1063.

11.

Bass

(2012) Circadian topology of metabolism. Nature 491:348-356.

12.

Bittman

Doherty

Huang

Paroskie

(2003) Period gene expression in mouse endocrine tissues. Am J Physiol Regul Integr Comp Physiol 285:R561-R569.

13.

Brezinschek

Gruschwitz

Sgonc

Moormann

Herold

Gershwin

Wick

(1993) Effects of cytokine application on glucocorticoid secretion in an animal model for systemic scleroderma. J Autoimmun 6:719-733.

14.

Brown

Kowalska

Dallmann

(2012) (Re)inventing the circadian feedback loop. Dev Cell 22:477-487.

15.

Buenafe

(2012) Diurnal rhythms are altered in a mouse model of multiple sclerosis. J Neuroimmunol 243:12-17.

16.

Buijs

Kalsbeek

van der Woude

van Heerikhuize

Shinn

(1993) Suprachiasmatic nucleus lesion increases corticosterone secretion. Am J Physiol 264:R1186-R1192.

17.

Buijs

Wortel

Van Heerikhuize

Feenstra

Ter Horst

Romijn

Kalsbeek

(1999) Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci 11:1535-1544.

18.

Buren

Bergstrom

Loh

Soderstrom

Olsson

Mattsson

(2007) Hippocampal 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese Zucker rat. Endocrinology 148:2716-2722.

19.

Burioka

Fukuoka

Koyanagi

Miyata

Takata

Chikumi

Takane

Watanabe

Endo

Sako

. (2010) Asthma: Chronopharmacotherapy and the molecular clock. Adv Rug Deliv Rev 62:946-955.

20.

Busillo

Cidlowski

(2013) The five Rs of glucocorticoid action during inflammation: Ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab 24:109-119.

21.

Cermakian

Lange

Golombek

Sarkar

Nakao

Shibata

Mazzoccoli

(2013) Crosstalk between the circadian clock circuitry and the immune system. Chronobiol Int 30:870-888.

22.

Cohen

Cole

Sood

Prinsloo

Kirschbaum

Arevalo

Jennings

Scott

Vence

. (2012) Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PloS One 7:e42324.

23.

Coursin

Wood

(2002) Corticosteroid supplementation for adrenal insufficiency. JAMA 287:236-240.

24.

Curtis

Cheng

Kapoor

Reilly

Price

Fitzgerald

(2007) Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc Natl Acad Sci U S A 104:3450-3455.

25.

Cutolo

Sulli

Pizzorni

Secchi

Soldano

Seriolo

Straub

Otsa

Maestroni

(2006) Circadian rhythms: glucocorticoids and arthritis. Ann N Y Acad Sci 1069:289-299.

26.

de Kloet

Joels

Holsboer

(2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463-475.

27.

de Kloet

Vreugdenhil

Oitzl

Joels

(1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301.

28.

Debono

Ross

Newell-Price

(2009) Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol 160:719-729.

29.

Dekkers

Geenen

Godaert

Glaudemans

Lafeber

van Doornen

Bijlsma

(2001) Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis. J Rheumatol 28:1496-1504.

30.

Dibner

Schibler

Albrecht

(2010) The mammalian circadian timing system: Organization and coordination of central and peripheral clocks. Annu Rev Physiol 72:517-549.

31.

Dickmeis

Foulkes

(2011) Glucocorticoids and circadian clock control of cell proliferation: At the interface between three dynamic systems. Mol Cell Endocrinol 331:11-22.

32.

Dickmeis

Lahiri

Nica

Vallone

Santoriello

Neumann

Hammerschmidt

Foulkes

(2007) Glucocorticoids play a key role in circadian cell cycle rhythms. PLoS Biol 5:e78.

33.

Dickmeis

Weger

(2013) The circadian clock and glucocorticoids—interactions across many time scales. Mol Cell Endocrinol 380:2-15.

34.

Dimitrov

Benedict

Heutling

Westermann

Born

Lange

(2009) Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 113:5134-5143.

35.

Doi

(2012) Circadian clock-deficient mice as a tool for exploring disease etiology. Biol Pharm Bull 35:1385-1391.

36.

Doi

Takahashi

Komatsu

Yamazaki

Yamada

Haraguchi

Emoto

Okuno

Tsujimoto

Kanematsu

. (2010) Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 16:67-74.

37.

Dolci

Montaruli

Roveda

Barajon

Vizzotto

Grassi Zucconi

Carandente

(2003) Circadian variations in expression of the trkB receptor in adult rat hippocampus. Brain Res 994:67-72.

38.

Dubovsky

Arvikar

Stern

Axelrod

(2012) The neuropsychiatric complications of glucocorticoid use: Steroid psychosis revisited. Psychosomatics 53:103-115.

39.

Ehrhart-Bornstein

Hinson

Bornstein

Scherbaum

Vinson

(1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19:101-143.

40.

Engeland

(2013) Sensitization of endocrine organs to anterior pituitary hormones by the autonomic nervous system. Handb Clin Neurol 117:37-44.

41.

Engler

Pham

Liu

Fullerton

Clarke

Funder

(1990) Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection: II. Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary. Endocrinology 127:1956-1966.

42.

Fahrenkrug

Hannibal

Georg

(2008) Diurnal rhythmicity of the canonical clock genes Per1, Per2 and Bmal1 in the rat adrenal gland is unaltered after hypophysectomy. J Neuroendocrinol 20:323-329.

43.

Fassler

Dietrich

Kromer

Schwarz

Brezinschek

Wick

(1988) Diminished glucocorticoid tonus in obese strain (OS) chickens with spontaneous autoimmune thyroiditis: Increased plasma levels of a physicochemically unaltered corticosteroid-binding globulin but normal total corticosterone plasma concentration and normal glucocorticoid receptor contents in lymphoid tissues. J Steroid Biochem 30:375-379.

44.

Fassler

Schauenstein

Kromer

Schwarz

Wick

(1986) Elevation of corticosteroid-binding globulin in obese strain (OS) chickens: Possible implications for the disturbed immunoregulation and the development of spontaneous autoimmune thyroiditis. J Immunol 136:3657-3661.

45.

Filipski

Levi

(2006) Disruption of circadian coordination and malignant growth. Cancer Causes Control 17:509-514.

46.

Filipski

Subramanian

Carriere

Guettier

Barbason

Levi

(2009) Circadian disruption accelerates liver carcinogenesis in mice. Mut Res 680:95-105.

47.

Frank

Swartz

Kupfer

(2000) Interpersonal and social rhythm therapy: Managing the chaos of bipolar disorder. Biol Psychiatry 48:593-604.

48.

Pelicano

Liu

Huang

Lee

(2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41-50.

49.

Gauger

Sancar

(2005) Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 65:6828-6834.

50.

Gilhooley

Pinnock

Herbert

(2011) Rhythmic expression of per1 in the dentate gyrus is suppressed by corticosterone: Implications for neurogenesis. Neurosci Lett 489:177-181.

51.

Girotti

Weinberg

Spencer

(2009) Diurnal expression of functional and clock-related genes throughout the rat HPA axis: System-wide shifts in response to a restricted feeding schedule. Am J Physiol Endocrinol Metab 296:E888-E897.

52.

Guo

Petraglia

Nappi

Criscuolo

Ficarra

Salvestroni

Genazzani

Trentini

Genazzani

(1996) Bicuculline enhances the corticosterone secretion induced by lipopolysaccharide and interleukin-1 alpha in male rats. J Endocrinol Invest 19:83-87.

53.

Hampp

Ripperger

Houben

Schmutz

Blex

Perreau-Lenz

Brunk

Spanagel

Ahnert-Hilger

Meijer

. (2008) Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol 18:678-683.

54.

Haus

Sackett-Lundeen

Smolensky

(2012) Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications. Bull NYU Hosp Joint Dis 70(Suppl 1):3-10.

55.

Haus

Smolensky

(2013) Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev 17:273-284.

56.

Heaney

Phillips

Carroll

(2010) Ageing, depression, anxiety, social support and the diurnal rhythm and awakening response of salivary cortisol. Int J Psychophysiol 78:201-208.

57.

Henley

Russell

Douthwaite

Wood

Buchanan

Gibson

Woltersdorf

Catterall

Lightman

(2009) Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 94:4234-4242.

58.

Holsboer

(2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477-501.

59.

Hsu

Kuhn

(1988) The role of the adrenal in generating the diurnal variation in circulating levels of corticosteroid-binding globulin in the rat. Endocrinology 122:421-426.

60.

Huang

Herbert

(2006) Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol Psychiatry 59:619-624.

61.

Huscher

Thiele

Gromnica-Ihle

Hein

Demary

Dreher

Zink

Buttgereit

(2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119-1124.

62.

Husebye

Allolio

Arlt

Badenhoop

Bensing

Betterle

Falorni

Gan

Hulting

Kasperlik-Zaluska

. (2014) Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 275:104-115.

63.

Innominato

Roche

Palesh

Ulusakarya

Spiegel

Levi

(2014) The circadian timing system in clinical oncology. Ann Med 46:191-207.

64.

Ishida

Mutoh

Ueyama

Bando

Masubuchi

Nakahara

Tsujimoto

Okamura

(2005) Light activates the adrenal gland: Timing of gene expression and glucocorticoid release. Cell Metab 2:297-307.

65.

James

Wehr

Sack

Parry

Rogers

Rosenthal

(1986) The dexamethasone suppression test in seasonal affective disorder. Comp Psychiatry 27:224-226.

66.

Jarcho

Slavich

Tylova-Stein

Wolkowitz

Burke

(2013) Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder. Biol Psychol 93:150-158.

67.

Johannsson

Bergthorsdottir

Nilsson

Lennernas

Hedner

Skrtic

(2009) Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol 161:119-130.

68.

Johannsson

Nilsson

Bergthorsdottir

Burman

Dahlqvist

Ekman

Engstrom

Olsson

Ragnarsson

Ryberg

. (2012) Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: A prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 97:473-481.

69.

Joseph-Vanderpool

Rosenthal

Chrousos

Wehr

Skwerer

Kasper

Gold

(1991) Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: Clinical and pathophysiological implications. J Clin Endocrinol Metab 72:1382-1387.

70.

Kalsbeek

Liu

Lei

Timmermans

Foppen

Cailotto

Fliers

(2012) Differential involvement of the suprachiasmatic nucleus in lipopolysaccharide-induced plasma glucose and corticosterone responses. Chronobiol Int 29:835-849.

71.

Karatsoreos

(2014) Links between circadian rhythms and psychiatric disease. Front Behav Neurosci 8:162.

72.

Katz

(2011) Jet lag and psychotic disorders. Curr Psychiatry Rep 13:187-192.

73.

Keisari

Cincotta

Meier

Cincotta

(1999) Timed daily administration of prolactin and corticosteroid hormone reduces murine tumor growth and enhances immune reactivity. Chronobiol Int 16:315-333.

74.

Kennaway

(2010) Clock genes at the heart of depression. J Psychopharmacol 24:5-14.

75.

Kiessling

Eichele

Oster

(2010) Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag. J Clin Invest 120:2600-2609.

76.

Kim

Choi

Ahn

(2012) Association of worse prognosis with an aberrant diurnal cortisol rhythm in patients with advanced lung cancer. Chronobiol Int 29:1109-1120.

77.

Kjolhede

Gustafsson

Nelson

(2013) Overweight and obese children have lower cortisol levels than normal weight children. Acta Paediatr 103:295-299.

78.

Kohsaka

Laposky

Ramsey

Estrada

Joshu

Kobayashi

Turek

Bass

(2007) High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 6:414-421.

79.

Kollet

Vagima

D’Uva

Golan

Canaani

Itkin

Gur-Cohen

Kalinkovich

Caglio

Medaglia

. (2013) Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors. Leukemia 27:2006-2015.

80.

Kovac

Husse

Oster

(2009) A time to fast, a time to feast: The crosstalk between metabolism and the circadian clock. Mol Cells 28:75-80.

81.

Kraan

Dullaart

Pratt

Wolthers

Drayer

De Bruin

(1998) The daily cortisol production reinvestigated in healthy men: The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab 83:1247-1252.

82.

Kraft

Vianna

Martin

Leung

(1999) Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 103:66-71.

83.

Krieger

(1975) Rhythms of ACTH and corticosteroid secretion in health and disease, and their experimental modification. J Steroid Biochem 6:785-791.

84.

Kwon

Hermayer

(2013) Glucocorticoid-induced hyperglycemia. Am J Med Sci 345:274-277.

85.

Lamia

Papp

Barish

Uhlenhaut

Jonker

Downes

Evans

(2011) Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 480:552-556.

86.

Lange

Dimitrov

Born

(2010) Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci 1193:48-59.

87.

Le Minh

Damiola

Tronche

Schutz

Schibler

(2001) Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators. Embo J 20:7128-7136.

88.

Lechner

Dietrich

Oliveira dos Santos

Wiegers

Schwarz

Harbutz

Herold

Wick

(2000) Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(Ipr) mice. J Autoimmun 14:325-333.

89.

Lederbogen

Hummel

Fademrecht

Krumm

Kuhner

Deuschle

Ladwig

Meisinger

Wichmann

Lutz

. (2011) Flattened circadian cortisol rhythm in type 2 diabetes. Exp Clin Endocrinol Diabetes 119:573-575.

90.

LeGates

Altimus

Wang

Lee

Yang

Zhao

Kirkwood

Weber

Hattar

(2012) Aberrant light directly impairs mood and learning through melanopsin-expressing neurons. Nature 491:594-598.

91.

LeGates

Fernandez

Hattar

(2014) Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci 15:443-454.

92.

Leliavski

Shostak

Husse

Oster

(2014) Impaired glucocorticoid production and response to stress in Arntl-deficient male mice. Endocrinology 155:133-142.

93.

Lemos

Downs

Urbanski

(2006) Twenty-four-hour rhythmic gene expression in the rhesus macaque adrenal gland. Mol Endocrinol 20:1164-1176.

94.

Lemos

Goodspeed

Tonelli

Antoch

Ojeda

Urbanski

(2007) Evidence for circadian regulation of activating transcription factor 5 but not tyrosine hydroxylase by the chromaffin cell clock. Endocrinology 148:5811-5821.

95.

Levi

Okyar

Dulong

Innominato

Clairambault

(2010) Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol 50:377-421.

96.

Bunney

Meng

Hagenauer

Walsh

Vawter

Evans

Choudary

Cartagena

Barchas

. (2013a) Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A 110:9950-9955.

97.

Liu

Gao

Wang

Zhang

(2013b) Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology 38:2789-2799.

98.

Lightman

Conway-Campbell

(2010) The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci 11:710-718.

99.

Lilley

Wotus

Taylor

Lee

de la Iglesia

(2012) Circadian regulation of cortisol release in behaviorally split golden hamsters. Endocrinology 153:732-738.

100.

Liston

Cichon

Jeanneteau

Jia

Chao

Gan

(2013) Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance. Nat Neurosci 16:698-705.

101.

Ljung

Andersson

Bengtsson

Bjorntorp

Marin

(1996) Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: A dose-response study. Obes Res 4:277-282.

102.

Ljung

Holm

Friberg

Andersson

Bengtsson

Svensson

Dallman

McEwen

Bjorntorp

(2000) The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men. Obes Res 8:487-495.

103.

Lovas

Gjesdal

Christensen

Wolff

Almas

Svartberg

Fougner

Syversen

Bollerslev

Falch

. (2009) Glucocorticoid replacement therapy and pharmacogenetics in Addison’s disease: Effects on bone. Eur J Endocrinol 160:993-1002.

104.

Lovas

Husebye

(2007) Continuous subcutaneous hydrocortisone infusion in Addison’s disease. Eur J Endocrinol 157:109-112.

105.

Lovas

Husebye

Holsten

Bjorvatn

(2003) Sleep disturbances in patients with Addison’s disease. Eur J Endocrinol 148:449-456.

106.

Martin

Wangsness

Gahagan

(1978) Diurnal changes in serum metabolites and hormones in lean and obese Zucker rats. Hormone Metab Res 10:187-192.

107.

McClung

(2013) How might circadian rhythms control mood? Let me count the ways. Biol Psychiatry 74:242-249.

108.

Megdal

Kroenke

Laden

Pukkala

Schernhammer

(2005) Night work and breast cancer risk: A systematic review and meta-analysis. Eur J Cancer 41:2023-2032.

109.

Meier

(1976) Daily variation in concentration of plasma corticosteroid in hypophysectomized rats. Endocrinology 98:1475-1479.

110.

Milhiet

Etain

Boudebesse

Bellivier

(2011) Circadian biomarkers, circadian genes and bipolar disorders. J Physiol 105:183-189.

111.

Moore

Eichler

(1972) Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 42:201-206.

112.

Mora

Segovia

Del Arco

de Blas

Garrido

(2012) Stress, neurotransmitters, corticosterone and body-brain integration. Brain Res 1476:71-85.

113.

Mormont

Levi

(1997) Circadian-system alterations during cancer processes: A review. Int J Cancer 70:241-247.

114.

Muglia

Jacobson

Weninger

Luedke

Bae

Jeong

Majzoub

(1997) Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J Clin Invest 99:2923-2929.

115.

Nader

Chrousos

Kino

(2009) Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J 23:1572-1583.

116.

Nader

Chrousos

Kino

(2010) Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab 21:277-286.

117.

Nilsson

Marelli

Fitts

Bergthorsdottir

Burman

Dahlqvist

Ekman

Eden Engstrom

Olsson

Ragnarsson

. (2014) Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency. Eur J Endocrinol 171:369-377.

118.

Oishi

Amagai

Shirai

Kadota

Ohkura

Ishida

(2005) Genome-wide expression analysis reveals 100 adrenal gland-dependent circadian genes in the mouse liver. DNA Res 12:191-202.

119.

Oliver

Sobczyk

Maywood

Edwards

Lee

Livieratos

Oster

Butler

Godinho

Wulff

. (2012) Disrupted circadian rhythms in a mouse model of schizophrenia. Curr Biol 22:314-319.

120.

Onyike

Crum

Lee

Lyketsos

Eaton

(2003) Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 158:1139-1147.

121.

Oren

Levendosky

Kasper

Duncan

Rosenthal

(1996) Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder. Biol Psychiatry 39:157-170.

122.

Oster

Damerow

Hut

Eichele

(2006a) Transcriptional profiling in the adrenal gland reveals circadian regulation of hormone biosynthesis genes and nucleosome assembly genes. J Biol Rhythms 21:350-361.

123.

Oster

Damerow

Kiessling

Jakubcakova

Abraham

Tian

Hoffmann

Eichele

(2006b) The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab 4:163-173.

124.

Ota

Fustin

Yamada

Doi

Okamura

(2012) Circadian clock signals in the adrenal cortex. Mol Cell Endocrinol 349:30-37.

125.

Ottenweller

Meier

(1982) Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology 111:1334-1338.

126.

Pearson

Schmidt

Patton

Dwyer

Blizzard

Otahal

Venn

(2010) Depression and insulin resistance: Cross-sectional associations in young adults. Diabetes Care 33:1128-1133.

127.

Pereira

Tiemensma

Romijn

(2010) Neuropsychiatric disorders in Cushing’s syndrome. Neuroendocrinology 92(Suppl 1):65-70.

128.

Perry

Kirwan

Jessop

Hunt

(2009) Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 68:63-68.

129.

Pezuk

Mohawk

Wang

Menaker

(2012) Glucocorticoids as entraining signals for peripheral circadian oscillators. Endocrinology 153:4775-4783.

130.

Pinnock

Herbert

(2008) Brain-derived neurotropic factor and neurogenesis in the adult rat dentate gyrus: interactions with corticosterone. Eur J Neurosci 27:2493-2500.

131.

Plat

Leproult

L’Hermite-Baleriaux

Fery

Mockel

Polonsky

Van Cauter

(1999) Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab 84:3082-3092.

132.

Purnell

Brandon

Isabelle

Loriaux

Samuels

(2004) Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 89:281-287.

133.

Quax

Manenschijn

Koper

Hazes

Lamberts

van Rossum

Feelders

(2013) Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol 9:670-686.

134.

Reul

de Kloet

(1985) Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 117:2505-2511.

135.

Rosmond

Chagnon

Bouchard

Bjorntorp

(2002) Polymorphism in exon 4 of the human 3 beta-hydroxysteroid dehydrogenase type I gene (HSD3B1) and blood pressure. Biochem Biophys Res Commun 293:629-632.

136.

Rosmond

Dallman

Bjorntorp

(1998) Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853-1859.

137.

Roybal

Theobold

Graham

DiNieri

Russo

Krishnan

Chakravarty

Peevey

Oehrlein

Birnbaum

. (2007) Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 104:6406-6411.

138.

Russell

Durant

Ataya

Papastathi

Bhake

Woltersdorf

Lightman

(2014) Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 81:289-293.

139.

Sage

Ganem

Guillaumond

Laforge-Anglade

Francois-Bellan

Bosler

Becquet

(2004) Influence of the corticosterone rhythm on photic entrainment of locomotor activity in rats. J Biol Rhythms 19:144-156.

140.

Saito

Bray

(1983) Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice. Endocrinology 113:2181-2185.

141.

Salvadore

Quiroz

Machado-Vieira

Henter

Manji

Zarate

Jr. (2010) The neurobiology of the switch process in bipolar disorder: A review. J Clin Psychiatry 71:1488-1501.

142.

Sarabdjitsingh

Spiga

Oitzl

Kershaw

Meijer

Lightman

de Kloet

(2010) Recovery from disrupted ultradian glucocorticoid rhythmicity reveals a dissociation between hormonal and behavioural stress responsiveness. J Neuroendocrinol 22:862-871.

143.

Sarlis

Chowdrey

Stephanou

Lightman

(1992) Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 130:1775-1779.

144.

Schaaf

Duurland

de Kloet

Vreugdenhil

(2000) Circadian variation in BDNF mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 75:342-344.

145.

Schauenstein

Fassler

Dietrich

Schwarz

Kromer

Wick

(1987) Disturbed immune-endocrine communication in autoimmune disease: lack of corticosterone response to immune signals in obese strain chickens with spontaneous autoimmune thyroiditis. J Immunol 139:1830-1833.

146.

Schernhammer

Laden

Speizer

Willett

Hunter

Kawachi

Colditz

(2001) Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. J Natl Cancer Inst 93:1563-1568.

147.

Segall

Milet

Tronche

Amir

(2009) Brain glucocorticoid receptors are necessary for the rhythmic expression of the clock protein, PERIOD2, in the central extended amygdala in mice. Neurosci Lett 457:58-60.

148.

Sephton

Lush

Dedert

Floyd

Rebholz

Dhabhar

Spiegel

Salmon

(2013) Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav Immun 30(Suppl):S163-S170.

149.

Sephton

Sapolsky

Kraemer

Spiegel

(2000) Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92:994-1000.

150.

Shimodaira

Nakayama

Sato

Naganuma

Yamaguchi

Aoi

Sato

Izumi

Soma

Matsumoto

(2010) Association study of the elastin microfibril interfacer 1 (EMILIN1) gene in essential hypertension. Am J Hypertens 23:547-555.

151.

Skwerer

Jacobsen

Duncan

Kelly

Sack

Tamarkin

Gaist

Kasper

Rosenthal

(1988) Neurobiology of seasonal affective disorder and phototherapy. J Biol Rhythms 3:135-154.

152.

Bernal

Pillsbury

Yamamoto

Feldman

(2009) Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc Natl Acad Sci U S A 106:17582-17587.

153.

Son

Chung

Choe

Kim

Baik

Lee

Choi

Sun

Kim

. (2008) Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc Natl Acad Sci U S A 105:20970-20975.

154.

Stephan

Zucker

(1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A 69:1583-1586.

155.

Stevens

(2009) Working against our endogenous circadian clock: Breast cancer and electric lighting in the modern world. Mut Res 680:106-108.

156.

Stevens

Hansen

Costa

Haus

Kauppinen

Aronson

Castano-Vinyals

Davis

Frings-Dresen

Fritschi

. (2011) Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report. Occup Environ Med 68:154-162.

157.

Terazono

Mutoh

Yamaguchi

Kobayashi

Akiyama

Udo

Ohdo

Okamura

Shibata

(2003) Adrenergic regulation of clock gene expression in mouse liver. Proc Natl Acad Sci U S A 100:6795-6800.

158.

Ulrich-Lai

Arnhold

Engeland

(2006) Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH. Am J Physiol Regul Integr Comp Physiol 290:R1128-R1135.

159.

Ulrich-Lai

Herman

(2009) Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 10:397-409.

160.

Valenzuela

Torres-Farfan

Richter

Mendez

Campino

Torrealba

Valenzuela

Seron-Ferre

(2008) Clock gene expression in adult primate suprachiasmatic nuclei and adrenal: is the adrenal a peripheral clock responsive to melatonin? Endocrinology 149:1454-1461.

161.

Van Cauter

Linkowski

Kerkhofs

Hubain

L’Hermite-Baleriaux

Leclercq

Brasseur

Copinschi

Mendlewicz

(1991) Circadian and sleep-related endocrine rhythms in schizophrenia. Arch Gen Psychiatry 48:348-356.

162.

van den Heiligenberg

Depres-Brummer

Barbason

Claustrat

Reynes

Levi

(1999) The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 64:2523-2534.

163.

Volden

Conzen

(2013) The influence of glucocorticoid signaling on tumor progression. Brain Behav Immun 30(Suppl):S26-S31.

164.

Wagner

Born

(2008) Memory consolidation during sleep: interactive effects of sleep stages and HPA regulation. Stress 11:28-41.

165.

Waite

McKenna

Kershaw

Walker

Cho

Piggins

Lightman

(2012) Ultradian corticosterone secretion is maintained in the absence of circadian cues. Eur J Neurosci 36:3142-3150.

166.

Walker

Soderberg

Lindahl

Olsson

(2000) Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J Intern Med 247:198-204.

167.

Walker

Scribner

Stern

Dallman

(1992) Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough. Endocrinology 131:2629-2637.

168.

Walker

Spiga

Waite

Zhao

Kershaw

Terry

Lightman

(2012) The origin of glucocorticoid hormone oscillations. PLoS Biol 10:e1001341.

169.

Watts

Tanimura

Sanchez-Watts

(2004) Corticotropin-releasing hormone and arginine vasopressin gene transcription in the hypothalamic paraventricular nucleus of unstressed rats: Daily rhythms and their interactions with corticosterone. Endocrinology 145:529-540.

170.

Webster

Knable

O’Grady

Orthmann

Weickert

(2002) Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 7:985-994, 924.

171.

Weingarten

Collop

(2013) Air travel: Effects of sleep deprivation and jet lag. Chest 144:1394-1401.

172.

Weinrib

Sephton

Degeest

Penedo

Bender

Zimmerman

Kirschbaum

Sood

Lubaroff

Lutgendorf

(2010) Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer 116:4410-4419.

173.

Wick

Schwarz

Kroemer

(1993) Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr Rev 14:539-563.

174.

Wolfe

Gordon

Island

Liddle

(1966) An analysis of factors determining the circadian pattern of aldosterone excretion. J Clin Endocrinol Metab 26:1261-1266.

175.

Wotus

Lilley

Neal

Suleiman

Schmuck

Smarr

Fischer

de la Iglesia

(2013) Forced desynchrony reveals independent contributions of suprachiasmatic oscillators to the daily plasma corticosterone rhythm in male rats. PLoS One 8:e68793.

176.

Wulff

Gatti

Wettstein

Foster

(2010) Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci 11:589-599.

177.

Yang

Downes

Bookout

Straume

Mangelsdorf

Evans

(2006) Nuclear receptor expression links the circadian clock to metabolism. Cell 126:801-810.

178.

Yehuda

Golier

Kaufman

(2005) Circadian rhythm of salivary cortisol in Holocaust survivors with and without PTSD. Am J Psychiatry 162:998-1000.

179.

Yoder

Brandeland

Engeland

(2014) Phase-dependent resetting of the adrenal clock by ACTH in vitro. Am J Physiol Regul Integr Comp Physiol 306:R387-R393.

Adrenal Clocks and the Role of Adrenal Hormones in the Regulation of Circadian Physiology

Abstract

Keywords

Control of Adrenal Hormone Rhythms

Clinical Implications of Adrenal GC Rhythms

GC Rhythms and Mood Disorders

GC Rhythms and Metabolic Disorders

GC Rhythms and Inflammatory Disorders

GC Rhythms and Cancer

GC Chronotherapy

Conclusion

Footnotes

Acknowledgements

Author Contributions

Conflict of Interest Statement

References